Zacks.com on MSN
5 Big Drug Stocks That May Continue to Outperform in 2026
After a weak first half, the drug and biotech sector has recovered in the past 2-3 months, with most large drugmakers signing drug pricing agreements with the Trump administration. After a cautious ...
Zacks Investment Research on MSN
Novo Nordisk vs. Amgen: Which healthcare stock is the smarter choice?
Both Novo Nordisk NVO and Amgen AMGN are large-cap, innovation-driven healthcare leaders with global scale, strong balance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results